Insulin Resistance: The Increased Risk of Cancers
Current Oncology · 13.02.2024 · 31 (2) · 998-1027
DOI: 10.3390/curroncol31020075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 13.02.2024. Verfasst von Leszek Szablewski. Beteiligte Einrichtung: Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5 Str., 02-004 Warsaw, Poland. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Hyperinsulinism. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Insulin resistance, also known as impaired insulin sensitivity, is the result of a decreased reaction of insulin signaling to blood glucose levels. This state is observed when muscle cells, adipose tissue, and liver cells, improperly respond to a particular concentration of insulin. Insulin resistance and related increased plasma insulin levels (hyperinsulinemia) may cause metabolic impairments, which are pathological states observed in obesity and type 2 diabetes mellitus. Observations of cancer patients confirm that hyperinsulinemia is a major factor influencing obesity, type 2 diabetes, and cancer. Obesity and diabetes have been reported as risks of the initiation, progression, and metastasis of several cancers. However, both of the aforementioned pathologies may independently and additionally increase the cancer risk. The state of metabolic disorders observed in cancer patients is associated with poor outcomes of cancer treatment. For example, patients suffering from metabolic disorders have higher cancer recurrence rates and their overall survival is reduced. In these associations between insulin resistance and cancer risk, an overview of the various pathogenic mechanisms that play a role in the development of cancer is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5 Str., 02-004 Warsaw, Poland.
Zitieren
APA
Szablewski, L. (2024). Insulin Resistance: The Increased Risk of Cancers. Current Oncology, 31(2), 998-1027. https://doi.org/10.3390/curroncol31020075
Vancouver
Szablewski L. Insulin Resistance: The Increased Risk of Cancers. Current Oncology. 2024;31(2):998-1027. doi:10.3390/curroncol31020075
BibTeX
@article{Szablewski2024,
author = {Szablewski, Leszek},
title = {Insulin Resistance: The Increased Risk of Cancers},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {2},
pages = {998--1027},
doi = {10.3390/curroncol31020075}
}
EUVIMED